Correlation Between Enlivex Therapeutics and Eupraxia Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Enlivex Therapeutics and Eupraxia Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enlivex Therapeutics and Eupraxia Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enlivex Therapeutics and Eupraxia Pharmaceuticals, you can compare the effects of market volatilities on Enlivex Therapeutics and Eupraxia Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enlivex Therapeutics with a short position of Eupraxia Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enlivex Therapeutics and Eupraxia Pharmaceuticals.
Diversification Opportunities for Enlivex Therapeutics and Eupraxia Pharmaceuticals
0.52 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Enlivex and Eupraxia is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Enlivex Therapeutics and Eupraxia Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eupraxia Pharmaceuticals and Enlivex Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enlivex Therapeutics are associated (or correlated) with Eupraxia Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eupraxia Pharmaceuticals has no effect on the direction of Enlivex Therapeutics i.e., Enlivex Therapeutics and Eupraxia Pharmaceuticals go up and down completely randomly.
Pair Corralation between Enlivex Therapeutics and Eupraxia Pharmaceuticals
Given the investment horizon of 90 days Enlivex Therapeutics is expected to under-perform the Eupraxia Pharmaceuticals. In addition to that, Enlivex Therapeutics is 1.37 times more volatile than Eupraxia Pharmaceuticals. It trades about -0.01 of its total potential returns per unit of risk. Eupraxia Pharmaceuticals is currently generating about 0.02 per unit of volatility. If you would invest 297.00 in Eupraxia Pharmaceuticals on November 4, 2024 and sell it today you would lose (18.00) from holding Eupraxia Pharmaceuticals or give up 6.06% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 66.67% |
| Values | Daily Returns |
Enlivex Therapeutics vs. Eupraxia Pharmaceuticals
Performance |
| Timeline |
| Enlivex Therapeutics |
| Eupraxia Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Enlivex Therapeutics and Eupraxia Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enlivex Therapeutics and Eupraxia Pharmaceuticals
The main advantage of trading using opposite Enlivex Therapeutics and Eupraxia Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enlivex Therapeutics position performs unexpectedly, Eupraxia Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eupraxia Pharmaceuticals will offset losses from the drop in Eupraxia Pharmaceuticals' long position.| Enlivex Therapeutics vs. Pluri Inc | Enlivex Therapeutics vs. BioLineRx | Enlivex Therapeutics vs. Purple Biotech | Enlivex Therapeutics vs. Histogen |
| Eupraxia Pharmaceuticals vs. Akeso, Inc | Eupraxia Pharmaceuticals vs. Ascletis Pharma | Eupraxia Pharmaceuticals vs. Avax Techs | Eupraxia Pharmaceuticals vs. Inhibrx |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |